RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
Bad and good news.
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @KindrachukJason: Great work to the Krammer lab!👏👏👏 https://t.co/XQEeq5gphs
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
RT @EricTopol: The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're get…
@CDPHE @GovofCO
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
The bad news: tests are dubious to facilitate safe reopening https://t.co/3OS3Limejp @natashanyt The good news: they're getting better, faster, cheaper, both for antigen/virus & antibodies https://t.co/XYrw3C7kBG @NatureMedicine https://t.co/suSFvBP
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
Great work to the Krammer lab!👏👏👏
And was exported sucessfully worldwide! ;-)
RT @nataliepica: Pushing the science forward @florian_krammer and other Sinai virology team members - well done, as always https://t.co/wKQ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
A serological assay to detect SARS-CoV-2 seroconversion in humans | Nature Medicine https://t.co/s3s5XTUfFy
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
Humans are serologically naive to SARS-CoV-2, which may explain the relatively high basic reproduction number (or R0) of SARS-CoV-2 compared with that of other respiratory viruses, such as influenza virus. https://t.co/LyXTUOPOEc
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
A serological assay to detect SARS-CoV-2 seroconversion in humans https://t.co/CejTU9X8W6 @DrJDrooghaag @evankirstel @Havenlust @Ronald_vanLoon @FrRonconi @2601Manish @bethlinas @mvollmer1 @Victoryabro @sallyeaves @DrUmeshPrabhu @kashthefuturist @gp_puli
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
Congrats, Dr. @florian_krammer and team! Excellent work! #COVID19 #AustrianScientistsinUS #Austria @ascina @OSTAustria_DC @AustriainUSA @IcahnMountSinai
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
Importante artículo donde desarrollan un test de detección ELISA que es altamente seguro y fiable. Discrimina contra otros coronavirus presentes en la gripe común, cosa que pocos test miran. Concretamente demuestra diferencias importantes en sus proteínas
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
"human coronaviruses OC43, 229E, NL63 and/or HKU1 are responsible for a large proportion of common colds every year, cross-reactivity between SARS-CoV-2 and these seasonal coronaviruses is of particular importance and warrants further investigation" #cross
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
This is how well serology works when well designed antigens are deployed! Congratulations @florian_krammer and team on this super useful publication!
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ABsteward: NEW @NatureMedicine @florian_krammer A serological assay to detect SARS-CoV-2 seroconversion in humans. #COVID19 @nataliexde…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @ScottGottliebMD: A best in class serological assay to detect SARS-CoV-2 antibodies in people who’ve had covid disease. https://t.co/giJ…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @thelonevirologi: A serological assay to detect SARS-CoV-2 seroconversion in humans by @florian_krammer https://t.co/lvD1Zc0qGJ
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…
RT @alt_fda: Are you promoting this because you have invested in the company? https://t.co/1OfwIRNz40
RT @florian_krammer: Our preprint from March 18th is now out in Nature Medicine: https://t.co/bRTtEKlx3c. So far this was used to screen >2…